全文获取类型
收费全文 | 2026篇 |
免费 | 231篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 156篇 |
妇产科学 | 26篇 |
基础医学 | 304篇 |
口腔科学 | 93篇 |
临床医学 | 228篇 |
内科学 | 431篇 |
皮肤病学 | 50篇 |
神经病学 | 97篇 |
特种医学 | 180篇 |
外科学 | 308篇 |
综合类 | 38篇 |
预防医学 | 129篇 |
眼科学 | 41篇 |
药学 | 70篇 |
中国医学 | 3篇 |
肿瘤学 | 127篇 |
出版年
2023年 | 15篇 |
2022年 | 13篇 |
2021年 | 27篇 |
2020年 | 19篇 |
2019年 | 16篇 |
2018年 | 63篇 |
2017年 | 52篇 |
2016年 | 53篇 |
2015年 | 72篇 |
2014年 | 89篇 |
2013年 | 119篇 |
2012年 | 73篇 |
2011年 | 60篇 |
2010年 | 92篇 |
2009年 | 109篇 |
2008年 | 64篇 |
2007年 | 87篇 |
2006年 | 83篇 |
2005年 | 54篇 |
2004年 | 58篇 |
2003年 | 37篇 |
2002年 | 35篇 |
2001年 | 31篇 |
2000年 | 34篇 |
1999年 | 43篇 |
1998年 | 104篇 |
1997年 | 89篇 |
1996年 | 100篇 |
1995年 | 66篇 |
1994年 | 80篇 |
1993年 | 45篇 |
1992年 | 24篇 |
1991年 | 34篇 |
1990年 | 27篇 |
1989年 | 46篇 |
1988年 | 47篇 |
1987年 | 34篇 |
1986年 | 29篇 |
1985年 | 26篇 |
1984年 | 17篇 |
1983年 | 9篇 |
1982年 | 21篇 |
1981年 | 16篇 |
1980年 | 18篇 |
1979年 | 7篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1976年 | 13篇 |
1975年 | 11篇 |
1967年 | 2篇 |
排序方式: 共有2288条查询结果,搜索用时 31 毫秒
91.
Hematopoietic growth factors (HGFs) interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) individually have been shown to increase the percentage of acute myeloid leukemia (AML) blasts in S phase and enhance the cytotoxic effects of Ara-C against these blasts in culture. We compared in vitro the effects of a combined treatment with GM-CSF (10 ng/mL) plus IL-3 (10 ng/mL) on the metabolism and cytotoxicity of Ara-C in normal bone marrow mononuclear cells (NBMMC) and AML blasts. NBMMC from six healthy volunteers and AML blasts from 10 patients were incubated for 20 hours with or without IL- 3 plus GM-CSF, followed by a concurrent treatment with Ara-C for 4 additional hours. Exposure to the HGFs and Ara-C produced significantly higher intracellular Ara-CTP levels as well as higher Ara-CTP/dCTP pool ratios in AML blasts as compared with NBMMC. Treatment with HGFs resulted in [3H] Ara-C DNA incorporation that was significantly higher in AML blasts versus NBMMC. This selective improvement of Ara-C metabolism in AML blasts was associated with an enhanced Ara-C-mediated leukemia colony-forming unit (CFU) growth inhibition. In contrast, exposure to HGFs resulted in an improved colony growth of normal CFU granulocyte-monocyte and CFU-granulocyte, erythroid, monocyte, megakaryocyte. These in vitro studies indicate that a combined treatment with IL-3 plus GM-CSF may improve the selectivity of Ara-C against AML blasts. 相似文献
92.
Lemos PA Serruys PW de Feyter P Mercado NF Goedhart D Saia F Arampatzis CA Soares PR Ciccone M Arquati M Cortellaro M Rutsch W Legrand V 《The American journal of cardiology》2005,95(4):445-451
Mild renal impairment is an important risk factor for late cardiovascular complications. This substudy of the Lescol Intervention Prevention Study (LIPS) assessed the effect of fluvastatin on outcome of patients who had renal dysfunction and those who did not. Complete data for creatinine clearance calculation (Cockcroft-Gault formula) were available for 1,558 patients (92.9% of the LIPS population). Patients were randomized to fluvastatin or placebo after successful completion of a first percutaneous coronary intervention. Follow-up time was 3 to 4 years. The effect of baseline creatinine clearance on coronary atherosclerotic events (cardiac death, nonfatal myocardial infarction, and coronary reinterventions not related to restenosis) was evaluated. Baseline creatinine clearance (logarithmic transformation) was inversely associated with an incidence of adverse events among patients who received placebo (hazard ratio 0.99, 95% confidence interval 0.982 to 0.998, p = 0.01). However, no association was noted between creatinine clearance and the incidence of adverse events among patients who received fluvastatin (hazard ratio 1.0, 95% confidence interval 0.99 to 1.0, p = 0.63). No further deterioration in creatinine clearance was observed during follow-up, regardless of baseline renal function or allocated treatment. Occurrence of adverse events was not related to changes in renal function during follow-up. Fluvastatin therapy markedly decreased the risk of coronary atherosclerotic events after percutaneous intervention in patients who had lower values of creatinine clearance at baseline. The benefit of fluvastatin was unrelated to any effect on renal function. 相似文献
93.
94.
95.
Romagnolo Alberto Balestrino Roberta Imbalzano Gabriele Ciccone Giovannino Riccardini Franco Artusi Carlo Alberto Bozzali Marco Ferrero Bruno Montalenti Elisa Montanaro Elisa Rizzone Mario Giorgio Vaula Giovanna Zibetti Maurizio Lopiano Leonardo 《Journal of neurology》2021,268(3):762-769
Journal of Neurology - Neurological symptoms of COVID-19 patients have been recently described. However, no comprehensive data have been reported on pre-existing neurological comorbidities and... 相似文献
96.
97.
98.
99.
Lineage-restricted regulation of the murine SCL/TAL-1 promoter 总被引:10,自引:2,他引:10
Bockamp EO; McLaughlin F; Murrell AM; Gottgens B; Robb L; Begley CG; Green AR 《Blood》1995,86(4):1502-1514
100.
Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice 总被引:15,自引:1,他引:15
The normal skin and other tissues of adult mast cell-deficient WBB6F1- W/Wv or WCB6F1-Sl/Sld mice contain less than 1.0% the number of mast cells present in the corresponding tissues of the congenic normal (+/+) mice. As a result, genetically mast cell-deficient WBB6F1-W/Wv or WCB6F1-Sl/Sld mice are widely used for studies of mast cell differentiation and function. We found that mast cells developed at sites of idiopathic chronic dermatitis in WBB6F1-W/Wv mice and that the number of mast cells present in the skin of WBB6F1-W/Wv mice was proportional to the severity of the dermatitis (in ear skin, there were 33 +/- 4 mast cells/mm2 of dermis at sites of severe dermatitis v 9 +/- 3 at sites of mild dermatitis, 0.8 +/- 0.3 in skin without dermatitis, and 100 +/- 7 in the normal skin of congenic WBB6F1-+/+ mice; in back skin, the corresponding values were 2.0 +/- 0.6, 1.1 +/- 0.9, 0.025 +/- 0.025, and 26.2 +/- 3.2). The development of mast cells was a local, not systemic, consequence of the dermatitis. Thus, WBB6F1-W/Wv mice with severe dermatitis lacked mast cells in skin not showing signs of dermatitis and also in the peritoneal cavity, stomach, cecum, and tongue. Idiopathic chronic dermatitis was not associated with the local development of mast cells in WCB6F1-Sl/Sld mice, a mutant whose mast cell deficiency is due to a mechanism distinct from that of WBB6F1-W/Wv mice. These findings may have implications for understanding the nature of the mast cell deficiency in WBB6F1-W/Wv and WCB6F1-Sl/Sld mice and for the use of these mutants to analyze mast cell differentiation and function. 相似文献